Probiotic helps reduce eczema in allergic infants

Related tags Probiotic bacteria Allergy Eczema

Adding the probiotic bacteria Lactobacillus GG (LGG) to the daily
diet of children with a food allergy helped to reduce eczema
symptoms, report researchers this month.

Previous trials have found this probiotic strain, produced by the Finnish dairy Valio, to lower the chances of children developing eczema.

A team from the University of Turku in Finland reported in 2003 that children who were exposed to the LGG bacteria around the time of birth were 40 per cent less likely to develop atopic eczema at four years of age compared with children in a placebo group.

In the new study, Dr Mirva Viljanen and colleagues from the University of Helsinki assessed symptoms in 230 infants who already had eczema, thought to be an allergy to cow's milk. Around 2-3 per cent of infants are allergic to milk proteins.

The children were given either LGG alone, LGG combined with three other probiotic bacteria, or a placebo for four weeks. They also followed a specific diet and skin treatment.

At the end of the treatment, the researchers tested for an allergy to cow's milk and found 120 infants to be allergic.

Allergy symptoms dropped by 65 per cent overall during the study, but no differences were observed between the different groups, write the researchers in this month's issue of Allergy​ (vol 60, issue 4, pp494-500).

However, when they looked only at subjects sensitized to the antibody IgE, shown to play a major role in allergies, the LGG treatment had a greater effect on symptom severity than placebo, or the probiotic combination.

Exclusion of infants who had received antibiotics during the study reinforced the findings in the IgE-sensitized subgroup, said the authors.

"Treatment with LGG may alleviate atopic eczema/dermatitis syndrome symptoms in IgE-sensitized infants but not in non-IgE-sensitized infants,"​ they report.

Related news

Show more

Related products

show more

Harness the power of algae for omega-3 innovation

Harness the power of algae for omega-3 innovation

Content provided by dsm-firmenich | 22-May-2024 | Insight Guide

Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...

Effera™ Human Equivalent Lactoferrin

Effera™ Human Equivalent Lactoferrin

Content provided by Helaina Inc | 17-May-2024 | Product Brochure

Helaina’s bioactive protein Effera™ is a novel branded ingredient and the first clinically studied Human Lactoferrin on the market. Human Lactoferrin is...

New postbiotic for gut & skin health benefits

New postbiotic for gut & skin health benefits

Content provided by Kerry ProActive Health | 14-May-2024 | Product Presentation

Plenibiotic™ (Lactobacillus casei subsp. casei 327) is a rice-derived postbiotic providing a holistic approach to digestive and skin health. It offers...

Related suppliers

Follow us

Products

View more

Webinars